MKC MCCORMICK & CO INC
Miscellaneous Food Preparations & Kindred Products · NYSE · SEC CIK 63754 · Fiscal year ends 11/30
Financial factors as of 2026-08-31 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY13.2%
TTM net income YoY91.6%
TTM EPS YoY92.0%
Revenue 3-yr CAGR5.2%
Net income 3-yr CAGR32.1%
Margins
Gross margin39.1%
Operating margin13.4%
Net margin19.4%
FCF margin12.0%
EBITDA margin17.0%
Returns
ROE23.4%
ROA10.0%
ROIC (approx.)7.6%
Asset turnover0.51x
Leverage & solvency
Liabilities / assets54.4%
Debt / equity0.53x
Current ratio0.66x
Interest coverage4.59x
Cash quality & payout
Operating cash flow / net income0.77x
Accruals ratio2.3%
Payout ratio34.1%
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-11-30 | FY20242024-11-30 | FY20232023-11-30 | FY20222022-11-30 | FY20212021-11-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $6.84B | $6.72B | $6.66B | $6.35B | $6.32B |
| Cost of revenue | $4.25B | $4.13B | $4.16B | $4.08B | $3.82B |
| Gross profit | $2.59B | $2.59B | $2.50B | $2.27B | $2.49B |
| R&D expense | $106.10M | $102.90M | $94.90M | $87.50M | $87.30M |
| SG&A expense | $1.50B | $1.52B | $1.48B | $1.36B | $1.40B |
| Operating income | $1.07B | $1.06B | $963.00M | $863.60M | $1.02B |
| Interest expense | $196.20M | $209.40M | $208.20M | $149.10M | $136.60M |
| Pretax income | $913.00M | $898.30M | $798.70M | $812.80M | $895.80M |
| Income tax | $195.80M | $184.00M | $174.50M | $168.60M | $192.70M |
| Net income | $789.40M | $788.50M | $680.60M | $682.00M | $755.30M |
| EBITDA | $1.30B | $1.27B | $1.16B | $1.06B | $1.20B |
| EPS (basic) | 2.94 | 2.94 | 2.54 | 2.54 | 2.83 |
| EPS (diluted) | 2.93 | 2.92 | 2.52 | 2.52 | 2.80 |
| Dividends declared per share | 1.83 | 1.71 | 1.59 | 1.50 | 1.39 |
| Weighted avg. shares (diluted) | 269.40M | 269.60M | 269.80M | 270.20M | 269.90M |
| Balance sheet | |||||
| Cash & equivalents | $95.90M | $186.10M | $166.60M | $334.00M | $351.70M |
| Receivables | $628.90M | $587.40M | $587.50M | $573.70M | $549.50M |
| Inventory | $1.27B | $1.24B | $1.13B | $1.34B | $1.18B |
| Current assets | $2.14B | $2.14B | $2.00B | $2.39B | $2.20B |
| PP&E, net | $1.45B | $1.41B | $1.32B | $1.20B | $1.14B |
| Goodwill | $5.30B | $5.23B | $5.26B | $5.21B | $5.34B |
| Intangibles | $3.29B | $3.32B | $3.36B | $3.39B | $3.45B |
| Total assets | $13.20B | $13.07B | $12.86B | $13.12B | $12.91B |
| Current liabilities | $3.06B | $2.88B | $3.10B | $3.43B | $3.22B |
| Short-term debt | $509.10M | $265.20M | $799.30M | $270.60M | $770.30M |
| Long-term debt | $3.11B | $3.59B | $3.34B | $3.64B | $3.97B |
| Total debt | $3.61B | $3.86B | $4.14B | $3.91B | $4.74B |
| Total liabilities | $7.43B | $7.75B | $7.78B | $8.43B | $8.48B |
| Shareholders' equity | $5.74B | $5.29B | $5.06B | $4.68B | $4.41B |
| Net debt | $3.52B | $3.67B | $3.97B | $3.58B | $4.39B |
| Cash flow statement | |||||
| Operating cash flow | $962.20M | $921.90M | $1.24B | $651.50M | $828.30M |
| Capital expenditure | $221.80M | $274.90M | $263.90M | $262.00M | $278.00M |
| Free cash flow | $740.40M | $647.00M | $973.40M | $389.50M | $550.30M |
| Investing cash flow | -$255.20M | -$269.00M | -$260.50M | -$146.40M | -$908.60M |
| Financing cash flow | -$840.90M | -$583.10M | -$1.18B | -$487.20M | $22.00M |
| Depreciation & amortization | $231.30M | $208.80M | $199.30M | $200.60M | $186.30M |
| Stock-based compensation | $46.20M | $47.40M | $63.40M | $60.30M | $66.60M |
| Dividends paid | $483.00M | $451.00M | $418.50M | $396.70M | $363.30M |
| Share buybacks | $34.80M | $53.10M | $35.70M | $38.80M | $8.60M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.